A Dearth of New Medications for Neuropsychiatric Disease on the Horizon


Neuropsychiatric diseases like schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease and more cost billions per year and account for 13% of the global burden of disease (a measure of years of life lost due to premature mortality and living in a state less than full health), according to the World Health Organization.

However, pharmaceutical companies have decided that generating new drugs to treat these disorders are simply too costly to pursue, and are pulling the plug on research and development in this area.

Read more here:  http://www.scientificamerican.com/article.cfm?id=a-dearth-of-new-meds

Mental Illness and the Sun

It’s l

It’s been known for a long time that winter-born babies are more likely to develop severe mental illness, including schizophrenia, depression and seasonal affective disorder.  Researchers at Vanderbilt and the University of Alabama may have identified clues as to how seasonal sunlight exposure could affect expression of clock genes that control our normal biological rhythms.